HBOT Conversations:
Laurie Anderson (Part 2)

Healing COVID with HBOT

 

Dr. Laurie is a Doctor of Pharmacy, and a graduate of the University of North Carolina – Chapel Hill (UNC-CH) School of Pharmacy and the Pharmacy Practice Residency Program at the University of California – San Francisco (UCSF).  Dr. Laurie spent many years in clinical practice, first as a neurosurgery clinical pharmacist at UCSF Medical Center and then as a general medicine and critical care clinical pharmacist at Duke Medical Center.  For the past 14 years Dr. Laurie has been working in industry, and is currently a safety scientist in early phase drug development, designing safety strategies for First Time in Human clinical trials.

Through her own journey navigating chronic illness, Dr. Laurie has explored and embraced many forms of alternative and non-traditional medicine to support her body for healing.  She has gravitated towards practitioners and modalities that treat the whole patient, with the mantra that tending to mind, body and spirit is the true key to lasting health.  Over the years, Dr. Laurie has discovered that this often leads to a ‘less is more’ approach. She discovered HBOT when she was struggling to heal from COVID, and now tells anyone who will listen about the power of oxygen and pressure.

Subscribe. Join the discussion. Share the hope.

Watch the Podcast

We continue Dr. Laurie Anderson’s HBOT News Network interview, diving in deeper to Hyperbaric Oxygen Therapy to heal COVID, and we bring up her struggles with Lyme Disease.  Her interview is being released as a three part series, with Part 1 being released last week.

This podcast starts with our host, Ed di Girolamo, explaining to the audience that he and Dr. Laurie had a brief conversation before the interview, and they discussed autoimmune diseases, or the mechanisms of autoimmune diseases, that would include inflammation or hypoxia.  He askes Dr. Laurie if this was discussed in her schooling when she got her doctorate in pharmacology. She explained that it was certainly talked about, but she really started to understand the trajectory of an underlying inflammatory process when she got sick.  To help her heal, she applied her own medical knowledge to her healing process, and explains —

“But that wasn’t a cornerstone of what we learned, and it really became a cornerstone of my own healing, that getting control of inflammation was the way that my immune system was going to ramp back up and that my body was going to heal, unequivocally.  It was all about addressing that inflammation.”

di Girolamo explains that years ago he attended a medical conference in Albuquerque that was specific to hyperbaric oxygen therapy, and he was on the edge of his seat for all three days.  It was then that he started to truly understand how to read the science of HBOT.  He brings up Lyme disease, which Dr. Laurie has personally struggled with, and recalls that there was a group of people there who have done HBOT and we’re so passionate in pushing it to help with Lyme disease because hyperbarics helped them, and they believe in it. di Girolamo states that through speaking to the medical profession about HBOT and Lyme, he has learned that Lyme disease is a virus and by doing a certain protocol of HBOT you’re essentially feeding the virus so much oxygen that it basically can not survive anymore and you “drown it”. 

As the conversation progresses about Lyme disease, Dr. Laurie lists some symptoms and how HBOT helped her with tremendously with sleeping. After her first treatment she slept for 12 hours, which was unheard of for her.  And she recalls that it was a very deep and refreshing sleep. She struggled for years and years with sleep from Lyme disease. Back then, HBOT was on the table as an alternative method of healing but she was only introduced to the mono-chambers and due to her extreme claustrophobia, it was not a healing avenue she wanted to explore at that time.  She is thankful for the large multi-place chambers at Extivita that allowed Dr. Laurie to take a leap of faith and finally try HBOT. 

Dr. Laurie’s career involves her reviewing the safety of clinical trials daily, so she explains that in order for a trial or study to be safe and effective, dosage is critical. di Girolamo explained that it’s the same for HBOT…. the right dosage of oxygen + pressure is critical to having healing success. He mentioned the podcasts with Dr. Stevens & Dr. Harch, as they both spoke in depth about dosage for hyperbaric oxygen therapy, especially for the indications that are considered to be “off label” for treatment with HBOT.   Every person is unique and what works for one might not work the same for the next, so dosage can be tricky. But, in the end di Girolamo explains — 

“I think at least in my conclusion, my humble opinion, is that any hyperbaric oxygen is better than no hyperbaric oxygen.”

Dr. Laurie referred to HBOT as a gift, because all that oxygen does so much for your brain. Which is exactly where it’s been proven to help veterans heal from PTSD, depression, anxiety, and even TBIs. She stresses that the mind-body connection is so strong, but it’s not talked about like it should be.  In her opinion, she thinks that all that oxygen is strengthening the mind-body connection to the point where the brain is receiving that surge of oxygen and basically then signal the body that it’s ok…. let’s heal. 

Stay tuned next week for Part 3 of Dr. Laurie’s podcast.

Guests

Elena Schertz, NP

Dr. Laurie Anderson, Pharm.D.

Dr. Laurie is a Doctor of Pharmacy, and a graduate of the University of North Carolina – Chapel Hill (UNC-CH) School of Pharmacy and the Pharmacy Practice Residency Program at the University of California – San Francisco (UCSF).  Dr. Laurie spent many years in clinical practice, first as a neurosurgery clinical pharmacist at UCSF Medical Center and then as a general medicine and critical care clinical pharmacist at Duke Medical Center.  For the past 14 years Dr. Laurie has been working in industry, and is currently a safety scientist in early phase drug development, designing safety strategies for First Time in Human clinical trials.

Through her own journey navigating chronic illness, Dr. Laurie has explored and embraced many forms of alternative and non-traditional medicine to support her body for healing.  She has gravitated towards practitioners and modalities that treat the whole patient, with the mantra that tending to mind, body and spirit is the true key to lasting health.  Over the years, Dr. Laurie has discovered that this often leads to a ‘less is more’ approach.

When not working, Dr. Laurie is an avid gardener, ballroom dancer and traveler with her husband. Remaining curious and finding joy in every day are her super powers.

Subscribe Now, It’s Free!

[contact-form-7 id="65934" title="Subscribe"]

Recent HBOT News

Clinical Trial – Transcranial Magnetic Stimulation and Hyperbaric Chamber for Women Fibromyalgia

Fibromyalgia syndrome (FMS) is a multisystem disease, characterized by generalized chronic
musculoskeletal pain. In addition, there is a lot of care for fatigue, sleep disorders,
morning stiffness, cognitive disorders, depression, anxiety and stress. Other common symptoms
are back pain, headaches, irritable bowel, balance problems and deterioration of physical
function in general. Patients with fibromyalgia (FM) often show pain at specific points that
are known as "tender spots or tender spots, with an increased sensitivity to painful stimuli"
(hyperalgesia) and a decreased pain threshold (allodynia). which can be evidenced in the
physical examination and in the absence of anomalies that justify in the biological or image
tests. These pain points to pressure, based on the most specific and specific criteria for
the diagnosis of the disease, traditionally based on the criteria of the American College of
Rheumatology (ACR), according to which, should be presented so minus 11 out of 18 painful
points to confirm it. Although the etiology remains unknown and unclear, its appearance is
attributed to a problem of central sensitization, that is, changes in central processing,
which causes an alteration of the mechanisms that regulate the sensation of pain, with
amplification of nociceptive input . and perpetuation of painful stimuli. Fibromyalgia is
becoming a common syndrome in the countries of Western Europe, with a prevalence in the
general population that ranges between 1-3%, and specifically in Spain, around 2.4%. In
addition, it has a higher incidence in women than men (73-95%), predominantly affecting women
between the ages of 40-50 years. About 3% of women with fibromyalgia are at an age when
menopause occurs, so not only do they experience the symptoms of both states but they even
exacerbate the syndrome with each other. On the other hand, and in relation to its
chronicity, the care of this type of patients involves large costs for society with a
significant consumption of health resources in the field of primary care, as well as the
costs of work absenteeism. For these reasons, it is considered an important problem with a
great impact on the health system, and therefore more and more studies are being developed
with the aim of better understanding the pathophysiology of this disease. The therapeutic
approach includes low cost and easy access measures, such as physical exercise (EF) programs
to improve the symptoms of FM. Physical exercise has positive effects directly on pain, joint
and muscle stiffness, generalized sensitivity and fatigue, among others, and secondarily on
cognitive disorders. Thus, the vast majority of studies focus on low-impact aerobic exercise,
performed between 60% and 70% of the maximum heart rate two to three times a week. However,
to date, there is no study that compares the effectiveness of physical exercise with other
innovative therapeutic actions, such as transcranial magnetic stimulation (TMS), the
hyperbaric chamber (HBOT), in parameters related to pain and quality of life. the life of
patients with fibromyalgia. The general objective is the effectiveness of transcranial
magnetic stimulation and the hyperbaric chamber in women with fibromyalgia. As specific
objectives we propose:

To assess the effect of HBOT, TMS and EF on quality of life in women with fibromyalgia.

– Object the effect of HBOT, TMS and EF in cortical functioning.

– Evaluate the effect of HBOT, TMS and EF on fatigue.

– Evaluate the effect of HBOT, TMS and EF on psychological aspects, such as depression and
anxiety.

– Evaluate the effect of HBOT, TMS and EF on the perception of pain and the number of
painful points.

– Evaluate the effect of HBOT, TMS and EF on the quality of sleep.

– Evaluate the effect of HBOT, TMS and EF on the quality of life.

– Evaluate the effect of HBOT, TMS and EF on the pain constructs.

– Determine the effect of HBOT, TMS and EF on plasma endorphin levels.